Megan Egbert — Representative Megan Egbert was called on regarding the minutes and then moved to approve the minutes from Tuesday, February 24, and Wednesday, February 25.
Megan Egbert — Representative Green explained that the bill is intentionally narrow and focused on treatments like chemotherapy, radiation, and surgery because those are medically known to have a greater impact on fertility. She said the committee could later consider whether alternative treatment methods should be incorporated, but deferred to clinicians on whether those alternatives also affect fertility.
Julie VanOrden — Referenced as being present and involved in the discussion.
Julie VanOrden — Identified herself as Senator Julie Van Orden from District 30 and added support for the resolution.
Julie VanOrden — Continued to support the resolution and explain the review panel's role.
Julie VanOrden — Referenced as speaking about the Medicaid review panel and consultation process.
Jordan Redman — Called on first for questions.
Jordan Redman — Moved to send HCR 30 to the floor with a do pass recommendation.
Jordan Redman — Identified as a member of the review panel.
Jordan Redman — Moved to introduce RS 33537.
Jordan Redman — Representative Redman made a Rule 80 declaration because he holds an insurance license and moved to send HJM 16 to the floor with a do-pass recommendation. He then clarified that he does not work in the Medicare market but still needed to declare Rule 80 due to his insurance license, thanked Director Cameron for the correction, and emphasized the importance of the measure for the marketplace and seniors.
Marco Erickson — Addressed during the discussion of the consultant and review process.
Ilana Rubel — Likely referenced as 'Senator Rubell' on the committee, though the title appears incorrect.
Ilana Rubel — The transcript appears to misrecognize a speaker name as 'Rebelle'; likely a reference to Representative Rubel in the procedural exchange.
James Petzke — Representative James Petzke discussed the bill’s fiscal and jurisdictional implications, noting that the permit fee is small and that any state revenue impact would come from permit fees, tobacco taxes, and sales taxes rather than a direct tax increase. He clarified that the bill would not raise tobacco tax rates, only potentially increase product sales, and explained that tobacco-related regulation involves the Department of Health and Welfare. He also remarked that the bill is business-focused but still germane to Health and Welfare, joking about another chairman taking the bill to his committee. The exchange then moved into a brief procedural follow-up in which a committee member was recognized and a question about the fiscal note was raised.
Robert Beiswenger — Questioned how the bill furthers the committee's health goal and expressed concern about tobacco products in a health committee.
Brooke Green — Representative Brooke Green introduced RS 33538 and explained that it would treat fertility preservation as medically necessary care for cancer patients of childbearing age. She described the urgency patients face when making fertility decisions under medical and emotional pressure, gave an example of a young Idaho woman with brain cancer who had to quickly come up with $12,000 for fertility preservation before surgery and treatment, and noted that chemotherapy, radiation, and some surgeries can permanently damage reproductive function. Green emphasized that the bill seeks only initial coverage for fertility preservation, not ongoing storage costs, and argued that it supports reproductive autonomy, families, and evidence-based care. She then stood for questions and later clarified that any fiscal impact would likely be absorbed through the state insurance plan or related costs, and that the bill was being brought for introduction and hearing purposes only, with no intention of advancing it that year.
fertility clinic provider — A fertility clinic was cited as providing the service, with four cases last year and two this year.
David Leavitt — Representative Ben Furman introduced House Joint Memorial 16, identified himself as representing District 30 in Bingham and Butte counties, and explained that insurance plans sold in Idaho must submit applications for approval to the Department of Insurance. He then noted that he had asked Director Cameron to attend to answer questions and thanked him for taking care of seniors.
Director Cameron — Director Cameron testified to correct the record on Medicare Advantage regulation, explaining that while plans file with CMS under federal law, they must also be licensed in Idaho and comply with state solvency and market-conduct requirements. He described concerns that some carriers made it difficult for seniors to access coverage, noted the importance of open enrollment and a department bulletin on unfair trade practices, and emphasized that the Department of Insurance and CMS are still defining their respective roles. He said the state has a memorandum of understanding with CMS and that the issue is important for protecting Idaho seniors. The exchange concluded with committee members thanking him for the clarification and additional information.